Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.91 |
| ▸ | GAA | P10253 | 7/20 | 0.91 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.91 |
| ▸ | MAPT | P10636 | 5/20 | 0.91 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | PARP1 | P09874 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.52 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15523572 | 0.98 | GAA (0.88) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL7968278 | 0.95 | ALDH1A1 (1.00) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL10502579 | 0.95 | ALDH1A1 (1.00) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL7981536 | 0.95 | ALDH1A1 (1.00) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL5710904 | 0.82 | ALDH1A1 (0.62) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL14754066 | 0.80 | KMT2A (0.61) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL8404564 | 0.79 | ALDH1A1 (0.67) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL38658291 | 0.78 | ALDH1A1 (0.65) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL25045478 | 0.77 | HTR2C (0.67) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL3234186 | 0.77 | HTR2C (0.67) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7790721-B2 | Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase | ABBOTT LABORATORIES (US) | 2010-09-07 | — | — | US | disclosed |
| US-20080161292-A1 | INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | ABBOTT LABORATORIES (US) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161292-A1 | INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | PARP1, PARP2, PARP3 | ALDH1A1 1358/4885GAA 565/4885KDM4E 4026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.